By Reuters
(Reuters) – German healthcare group Fresenius <FREG.DE> raised full-year revenue targets on Tuesday as its adjusted second-quarter sales came in a touch above analysts’ expectations.
The healthcare group said its second-quarter core operating profit (EBIT) fell by 5% to 1.08 billion euros (£991.67 million) on comparable basis, broadly in line with analysts’ expectations in a Refinitiv poll.
For 2019, the company expects revenue growth between 4% and 7% in constant currency, compared to the previous range of 3% to 6%.
(Reporting by Zuzanna Szymanska in Gdynia; Editing by Tomasz Janowski; Editing by Tomasz Janowski)
